MetaCap

Anbio Biotechnology SEC Filings

NASDAQ: NNNNHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD

4.66+0.04 (+0.87%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Anbio Biotechnology filing overview

This page lists 15 recent SEC filings by Anbio Biotechnology (NNNN), including 7 6-K, 3 F-1/A, 2 20-F, 1 20-F/A. Form 10-K is the audited annual report, 10-Q the quarterly report, 8-K covers material events, and Form 4 reports insider transactions. All documents link directly to SEC EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

NNNN SEC filings

Anbio Biotechnology SEC filings
FiledFormDescriptionDocument
May 19, 20266-KReport of foreign private issuerView on EDGAR
Apr 27, 20266-KReport of foreign private issuerView on EDGAR
Apr 9, 202620-F/AAnnual report (foreign private issuer) (amendment)View on EDGAR
Apr 7, 202620-FAnnual report (foreign private issuer)View on EDGAR
Feb 17, 20266-KReport of foreign private issuerView on EDGAR
Jan 26, 20266-KReport of foreign private issuerView on EDGAR
Dec 30, 20256-KREPORT OF FOREIGN PRIVATE ISSUERView on EDGAR
Nov 13, 20256-KREPORT OF FOREIGN PRIVATE ISSUERView on EDGAR
Apr 28, 202520-FANNUAL REPORTView on EDGAR
Feb 21, 20256-KREPORT OF FOREIGN PRIVATE ISSUERView on EDGAR
Feb 19, 2025424B4PROSPECTUSView on EDGAR
Feb 10, 2025F-1/AREGISTRATION STATEMENTView on EDGAR
Jan 24, 2025F-1/AREGISTRATION STATEMENTView on EDGAR
Jan 10, 2025F-1/AREGISTRATION STATEMENTView on EDGAR
Dec 31, 2024F-1REGISTRATION STATEMENTView on EDGAR

Related